They said increased marketing efforts and a joint venture with the small-business consulting arm of American Express will get growth back on track this year.
The company got a big shot in the arm on July 12, when the U.S. Food and Drug Administration granted fast-track status to the Canadian company's Fluviral flu vaccine.